Global Biologics Targeting CCR4 Market Growth 2026-2032
The global Biologics Targeting CCR4 market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
CCR4-targeted biologics are biologics used to treat specific diseases that inhibit or modulate the function of the CCR4 receptor. CCR4 is a cell surface receptor in the immune system that is often associated with regulating immune responses and cell movement. Such biologics are often designed to address abnormal CCR4 activity in certain diseases, particularly those involving the immune system. Among them, one of the most common application areas is the treatment of malignant lymphomas, especially T-cell lymphomas, such as lobectomy cell lymphoma and cutaneous T-cell lymphoma. CCR4 biologics can help inhibit tumor growth by interfering with CCR4 receptor signaling and limiting the proliferation and spread of malignant T cells.
United States market for Biologics Targeting CCR4 is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Biologics Targeting CCR4 is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Biologics Targeting CCR4 is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Biologics Targeting CCR4 players cover Kyowa, RAPT Therapeutics, Inc, Hanmi Pharmaceutical Co., Ltd, Eight Plus One Pharmaceutical Co Ltd, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Biologics Targeting CCR4 Industry Forecast” looks at past sales and reviews total world Biologics Targeting CCR4 sales in 2025, providing a comprehensive analysis by region and market sector of projected Biologics Targeting CCR4 sales for 2026 through 2032. With Biologics Targeting CCR4 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biologics Targeting CCR4 industry.
This Insight Report provides a comprehensive analysis of the global Biologics Targeting CCR4 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biologics Targeting CCR4 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biologics Targeting CCR4 market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biologics Targeting CCR4 and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biologics Targeting CCR4.
This report presents a comprehensive overview, market shares, and growth opportunities of Biologics Targeting CCR4 market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
CCR4-targeted biologics are biologics used to treat specific diseases that inhibit or modulate the function of the CCR4 receptor. CCR4 is a cell surface receptor in the immune system that is often associated with regulating immune responses and cell movement. Such biologics are often designed to address abnormal CCR4 activity in certain diseases, particularly those involving the immune system. Among them, one of the most common application areas is the treatment of malignant lymphomas, especially T-cell lymphomas, such as lobectomy cell lymphoma and cutaneous T-cell lymphoma. CCR4 biologics can help inhibit tumor growth by interfering with CCR4 receptor signaling and limiting the proliferation and spread of malignant T cells.
United States market for Biologics Targeting CCR4 is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Biologics Targeting CCR4 is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Biologics Targeting CCR4 is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Biologics Targeting CCR4 players cover Kyowa, RAPT Therapeutics, Inc, Hanmi Pharmaceutical Co., Ltd, Eight Plus One Pharmaceutical Co Ltd, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Biologics Targeting CCR4 Industry Forecast” looks at past sales and reviews total world Biologics Targeting CCR4 sales in 2025, providing a comprehensive analysis by region and market sector of projected Biologics Targeting CCR4 sales for 2026 through 2032. With Biologics Targeting CCR4 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biologics Targeting CCR4 industry.
This Insight Report provides a comprehensive analysis of the global Biologics Targeting CCR4 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biologics Targeting CCR4 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biologics Targeting CCR4 market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biologics Targeting CCR4 and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biologics Targeting CCR4.
This report presents a comprehensive overview, market shares, and growth opportunities of Biologics Targeting CCR4 market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Monoclonal Antibodies
- Small Molecule Chemicals
- S?zary Syndrome
- Mycosis Fungoides
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Kyowa
- RAPT Therapeutics, Inc
- Hanmi Pharmaceutical Co., Ltd
- Eight Plus One Pharmaceutical Co Ltd
- What is the 10-year outlook for the global Biologics Targeting CCR4 market?
- What factors are driving Biologics Targeting CCR4 market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Biologics Targeting CCR4 market opportunities vary by end market size?
- How does Biologics Targeting CCR4 break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biologics Targeting CCR4 Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Biologics Targeting CCR4 by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Biologics Targeting CCR4 by Country/Region, 2021, 2025 & 2032
2.2 Biologics Targeting CCR4 Segment by Type
2.2.1 Monoclonal Antibodies
2.2.2 Small Molecule Chemicals
2.2.3 Biologics Targeting CCR4 Sales by Type
2.2.3.1 Global Biologics Targeting CCR4 Sales Market Share by Type (2021-2026)
2.2.3.2 Global Biologics Targeting CCR4 Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Biologics Targeting CCR4 Sale Price by Type (2021-2026)
2.3 Biologics Targeting CCR4 Segment by Application
2.3.1 S?zary Syndrome
2.3.2 Mycosis Fungoides
2.3.3 Biologics Targeting CCR4 Sales by Application
2.3.3.1 Global Biologics Targeting CCR4 Sale Market Share by Application (2021-2026)
2.3.3.2 Global Biologics Targeting CCR4 Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Biologics Targeting CCR4 Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Biologics Targeting CCR4 Breakdown Data by Company
3.1.1 Global Biologics Targeting CCR4 Annual Sales by Company (2021-2026)
3.1.2 Global Biologics Targeting CCR4 Sales Market Share by Company (2021-2026)
3.2 Global Biologics Targeting CCR4 Annual Revenue by Company (2021-2026)
3.2.1 Global Biologics Targeting CCR4 Revenue by Company (2021-2026)
3.2.2 Global Biologics Targeting CCR4 Revenue Market Share by Company (2021-2026)
3.3 Global Biologics Targeting CCR4 Sale Price by Company
3.4 Key Manufacturers Biologics Targeting CCR4 Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Biologics Targeting CCR4 Product Location Distribution
3.4.2 Players Biologics Targeting CCR4 Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BIOLOGICS TARGETING CCR4 BY GEOGRAPHIC REGION
4.1 World Historic Biologics Targeting CCR4 Market Size by Geographic Region (2021-2026)
4.1.1 Global Biologics Targeting CCR4 Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Biologics Targeting CCR4 Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Biologics Targeting CCR4 Market Size by Country/Region (2021-2026)
4.2.1 Global Biologics Targeting CCR4 Annual Sales by Country/Region (2021-2026)
4.2.2 Global Biologics Targeting CCR4 Annual Revenue by Country/Region (2021-2026)
4.3 Americas Biologics Targeting CCR4 Sales Growth
4.4 APAC Biologics Targeting CCR4 Sales Growth
4.5 Europe Biologics Targeting CCR4 Sales Growth
4.6 Middle East & Africa Biologics Targeting CCR4 Sales Growth
5 AMERICAS
5.1 Americas Biologics Targeting CCR4 Sales by Country
5.1.1 Americas Biologics Targeting CCR4 Sales by Country (2021-2026)
5.1.2 Americas Biologics Targeting CCR4 Revenue by Country (2021-2026)
5.2 Americas Biologics Targeting CCR4 Sales by Type (2021-2026)
5.3 Americas Biologics Targeting CCR4 Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biologics Targeting CCR4 Sales by Region
6.1.1 APAC Biologics Targeting CCR4 Sales by Region (2021-2026)
6.1.2 APAC Biologics Targeting CCR4 Revenue by Region (2021-2026)
6.2 APAC Biologics Targeting CCR4 Sales by Type (2021-2026)
6.3 APAC Biologics Targeting CCR4 Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Biologics Targeting CCR4 by Country
7.1.1 Europe Biologics Targeting CCR4 Sales by Country (2021-2026)
7.1.2 Europe Biologics Targeting CCR4 Revenue by Country (2021-2026)
7.2 Europe Biologics Targeting CCR4 Sales by Type (2021-2026)
7.3 Europe Biologics Targeting CCR4 Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biologics Targeting CCR4 by Country
8.1.1 Middle East & Africa Biologics Targeting CCR4 Sales by Country (2021-2026)
8.1.2 Middle East & Africa Biologics Targeting CCR4 Revenue by Country (2021-2026)
8.2 Middle East & Africa Biologics Targeting CCR4 Sales by Type (2021-2026)
8.3 Middle East & Africa Biologics Targeting CCR4 Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Biologics Targeting CCR4
10.3 Manufacturing Process Analysis of Biologics Targeting CCR4
10.4 Industry Chain Structure of Biologics Targeting CCR4
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Biologics Targeting CCR4 Distributors
11.3 Biologics Targeting CCR4 Customer
12 WORLD FORECAST REVIEW FOR BIOLOGICS TARGETING CCR4 BY GEOGRAPHIC REGION
12.1 Global Biologics Targeting CCR4 Market Size Forecast by Region
12.1.1 Global Biologics Targeting CCR4 Forecast by Region (2027-2032)
12.1.2 Global Biologics Targeting CCR4 Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Biologics Targeting CCR4 Forecast by Type (2027-2032)
12.7 Global Biologics Targeting CCR4 Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Kyowa
13.1.1 Kyowa Company Information
13.1.2 Kyowa Biologics Targeting CCR4 Product Portfolios and Specifications
13.1.3 Kyowa Biologics Targeting CCR4 Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Kyowa Main Business Overview
13.1.5 Kyowa Latest Developments
13.2 RAPT Therapeutics, Inc
13.2.1 RAPT Therapeutics, Inc Company Information
13.2.2 RAPT Therapeutics, Inc Biologics Targeting CCR4 Product Portfolios and Specifications
13.2.3 RAPT Therapeutics, Inc Biologics Targeting CCR4 Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 RAPT Therapeutics, Inc Main Business Overview
13.2.5 RAPT Therapeutics, Inc Latest Developments
13.3 Hanmi Pharmaceutical Co., Ltd
13.3.1 Hanmi Pharmaceutical Co., Ltd Company Information
13.3.2 Hanmi Pharmaceutical Co., Ltd Biologics Targeting CCR4 Product Portfolios and Specifications
13.3.3 Hanmi Pharmaceutical Co., Ltd Biologics Targeting CCR4 Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Hanmi Pharmaceutical Co., Ltd Main Business Overview
13.3.5 Hanmi Pharmaceutical Co., Ltd Latest Developments
13.4 Eight Plus One Pharmaceutical Co Ltd
13.4.1 Eight Plus One Pharmaceutical Co Ltd Company Information
13.4.2 Eight Plus One Pharmaceutical Co Ltd Biologics Targeting CCR4 Product Portfolios and Specifications
13.4.3 Eight Plus One Pharmaceutical Co Ltd Biologics Targeting CCR4 Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Eight Plus One Pharmaceutical Co Ltd Main Business Overview
13.4.5 Eight Plus One Pharmaceutical Co Ltd Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biologics Targeting CCR4 Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Biologics Targeting CCR4 by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Biologics Targeting CCR4 by Country/Region, 2021, 2025 & 2032
2.2 Biologics Targeting CCR4 Segment by Type
2.2.1 Monoclonal Antibodies
2.2.2 Small Molecule Chemicals
2.2.3 Biologics Targeting CCR4 Sales by Type
2.2.3.1 Global Biologics Targeting CCR4 Sales Market Share by Type (2021-2026)
2.2.3.2 Global Biologics Targeting CCR4 Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Biologics Targeting CCR4 Sale Price by Type (2021-2026)
2.3 Biologics Targeting CCR4 Segment by Application
2.3.1 S?zary Syndrome
2.3.2 Mycosis Fungoides
2.3.3 Biologics Targeting CCR4 Sales by Application
2.3.3.1 Global Biologics Targeting CCR4 Sale Market Share by Application (2021-2026)
2.3.3.2 Global Biologics Targeting CCR4 Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Biologics Targeting CCR4 Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Biologics Targeting CCR4 Breakdown Data by Company
3.1.1 Global Biologics Targeting CCR4 Annual Sales by Company (2021-2026)
3.1.2 Global Biologics Targeting CCR4 Sales Market Share by Company (2021-2026)
3.2 Global Biologics Targeting CCR4 Annual Revenue by Company (2021-2026)
3.2.1 Global Biologics Targeting CCR4 Revenue by Company (2021-2026)
3.2.2 Global Biologics Targeting CCR4 Revenue Market Share by Company (2021-2026)
3.3 Global Biologics Targeting CCR4 Sale Price by Company
3.4 Key Manufacturers Biologics Targeting CCR4 Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Biologics Targeting CCR4 Product Location Distribution
3.4.2 Players Biologics Targeting CCR4 Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BIOLOGICS TARGETING CCR4 BY GEOGRAPHIC REGION
4.1 World Historic Biologics Targeting CCR4 Market Size by Geographic Region (2021-2026)
4.1.1 Global Biologics Targeting CCR4 Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Biologics Targeting CCR4 Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Biologics Targeting CCR4 Market Size by Country/Region (2021-2026)
4.2.1 Global Biologics Targeting CCR4 Annual Sales by Country/Region (2021-2026)
4.2.2 Global Biologics Targeting CCR4 Annual Revenue by Country/Region (2021-2026)
4.3 Americas Biologics Targeting CCR4 Sales Growth
4.4 APAC Biologics Targeting CCR4 Sales Growth
4.5 Europe Biologics Targeting CCR4 Sales Growth
4.6 Middle East & Africa Biologics Targeting CCR4 Sales Growth
5 AMERICAS
5.1 Americas Biologics Targeting CCR4 Sales by Country
5.1.1 Americas Biologics Targeting CCR4 Sales by Country (2021-2026)
5.1.2 Americas Biologics Targeting CCR4 Revenue by Country (2021-2026)
5.2 Americas Biologics Targeting CCR4 Sales by Type (2021-2026)
5.3 Americas Biologics Targeting CCR4 Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biologics Targeting CCR4 Sales by Region
6.1.1 APAC Biologics Targeting CCR4 Sales by Region (2021-2026)
6.1.2 APAC Biologics Targeting CCR4 Revenue by Region (2021-2026)
6.2 APAC Biologics Targeting CCR4 Sales by Type (2021-2026)
6.3 APAC Biologics Targeting CCR4 Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Biologics Targeting CCR4 by Country
7.1.1 Europe Biologics Targeting CCR4 Sales by Country (2021-2026)
7.1.2 Europe Biologics Targeting CCR4 Revenue by Country (2021-2026)
7.2 Europe Biologics Targeting CCR4 Sales by Type (2021-2026)
7.3 Europe Biologics Targeting CCR4 Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biologics Targeting CCR4 by Country
8.1.1 Middle East & Africa Biologics Targeting CCR4 Sales by Country (2021-2026)
8.1.2 Middle East & Africa Biologics Targeting CCR4 Revenue by Country (2021-2026)
8.2 Middle East & Africa Biologics Targeting CCR4 Sales by Type (2021-2026)
8.3 Middle East & Africa Biologics Targeting CCR4 Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Biologics Targeting CCR4
10.3 Manufacturing Process Analysis of Biologics Targeting CCR4
10.4 Industry Chain Structure of Biologics Targeting CCR4
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Biologics Targeting CCR4 Distributors
11.3 Biologics Targeting CCR4 Customer
12 WORLD FORECAST REVIEW FOR BIOLOGICS TARGETING CCR4 BY GEOGRAPHIC REGION
12.1 Global Biologics Targeting CCR4 Market Size Forecast by Region
12.1.1 Global Biologics Targeting CCR4 Forecast by Region (2027-2032)
12.1.2 Global Biologics Targeting CCR4 Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Biologics Targeting CCR4 Forecast by Type (2027-2032)
12.7 Global Biologics Targeting CCR4 Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Kyowa
13.1.1 Kyowa Company Information
13.1.2 Kyowa Biologics Targeting CCR4 Product Portfolios and Specifications
13.1.3 Kyowa Biologics Targeting CCR4 Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Kyowa Main Business Overview
13.1.5 Kyowa Latest Developments
13.2 RAPT Therapeutics, Inc
13.2.1 RAPT Therapeutics, Inc Company Information
13.2.2 RAPT Therapeutics, Inc Biologics Targeting CCR4 Product Portfolios and Specifications
13.2.3 RAPT Therapeutics, Inc Biologics Targeting CCR4 Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 RAPT Therapeutics, Inc Main Business Overview
13.2.5 RAPT Therapeutics, Inc Latest Developments
13.3 Hanmi Pharmaceutical Co., Ltd
13.3.1 Hanmi Pharmaceutical Co., Ltd Company Information
13.3.2 Hanmi Pharmaceutical Co., Ltd Biologics Targeting CCR4 Product Portfolios and Specifications
13.3.3 Hanmi Pharmaceutical Co., Ltd Biologics Targeting CCR4 Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Hanmi Pharmaceutical Co., Ltd Main Business Overview
13.3.5 Hanmi Pharmaceutical Co., Ltd Latest Developments
13.4 Eight Plus One Pharmaceutical Co Ltd
13.4.1 Eight Plus One Pharmaceutical Co Ltd Company Information
13.4.2 Eight Plus One Pharmaceutical Co Ltd Biologics Targeting CCR4 Product Portfolios and Specifications
13.4.3 Eight Plus One Pharmaceutical Co Ltd Biologics Targeting CCR4 Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Eight Plus One Pharmaceutical Co Ltd Main Business Overview
13.4.5 Eight Plus One Pharmaceutical Co Ltd Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Biologics Targeting CCR4 Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Biologics Targeting CCR4 Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Monoclonal Antibodies
Table 4. Major Players of Small Molecule Chemicals
Table 5. Global Biologics Targeting CCR4 Sales by Type (2021-2026) & (K Units)
Table 6. Global Biologics Targeting CCR4 Sales Market Share by Type (2021-2026)
Table 7. Global Biologics Targeting CCR4 Revenue by Type (2021-2026) & ($ million)
Table 8. Global Biologics Targeting CCR4 Revenue Market Share by Type (2021-2026)
Table 9. Global Biologics Targeting CCR4 Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Biologics Targeting CCR4 Sale by Application (2021-2026) & (K Units)
Table 11. Global Biologics Targeting CCR4 Sale Market Share by Application (2021-2026)
Table 12. Global Biologics Targeting CCR4 Revenue by Application (2021-2026) & ($ million)
Table 13. Global Biologics Targeting CCR4 Revenue Market Share by Application (2021-2026)
Table 14. Global Biologics Targeting CCR4 Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Biologics Targeting CCR4 Sales by Company (2021-2026) & (K Units)
Table 16. Global Biologics Targeting CCR4 Sales Market Share by Company (2021-2026)
Table 17. Global Biologics Targeting CCR4 Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Biologics Targeting CCR4 Revenue Market Share by Company (2021-2026)
Table 19. Global Biologics Targeting CCR4 Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Biologics Targeting CCR4 Producing Area Distribution and Sales Area
Table 21. Players Biologics Targeting CCR4 Products Offered
Table 22. Biologics Targeting CCR4 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Biologics Targeting CCR4 Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Biologics Targeting CCR4 Sales Market Share Geographic Region (2021-2026)
Table 27. Global Biologics Targeting CCR4 Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Biologics Targeting CCR4 Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Biologics Targeting CCR4 Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Biologics Targeting CCR4 Sales Market Share by Country/Region (2021-2026)
Table 31. Global Biologics Targeting CCR4 Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Biologics Targeting CCR4 Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Biologics Targeting CCR4 Sales by Country (2021-2026) & (K Units)
Table 34. Americas Biologics Targeting CCR4 Sales Market Share by Country (2021-2026)
Table 35. Americas Biologics Targeting CCR4 Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Biologics Targeting CCR4 Sales by Type (2021-2026) & (K Units)
Table 37. Americas Biologics Targeting CCR4 Sales by Application (2021-2026) & (K Units)
Table 38. APAC Biologics Targeting CCR4 Sales by Region (2021-2026) & (K Units)
Table 39. APAC Biologics Targeting CCR4 Sales Market Share by Region (2021-2026)
Table 40. APAC Biologics Targeting CCR4 Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Biologics Targeting CCR4 Sales by Type (2021-2026) & (K Units)
Table 42. APAC Biologics Targeting CCR4 Sales by Application (2021-2026) & (K Units)
Table 43. Europe Biologics Targeting CCR4 Sales by Country (2021-2026) & (K Units)
Table 44. Europe Biologics Targeting CCR4 Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Biologics Targeting CCR4 Sales by Type (2021-2026) & (K Units)
Table 46. Europe Biologics Targeting CCR4 Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Biologics Targeting CCR4 Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Biologics Targeting CCR4 Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Biologics Targeting CCR4 Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Biologics Targeting CCR4 Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Biologics Targeting CCR4
Table 52. Key Market Challenges & Risks of Biologics Targeting CCR4
Table 53. Key Industry Trends of Biologics Targeting CCR4
Table 54. Biologics Targeting CCR4 Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Biologics Targeting CCR4 Distributors List
Table 57. Biologics Targeting CCR4 Customer List
Table 58. Global Biologics Targeting CCR4 Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Biologics Targeting CCR4 Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Biologics Targeting CCR4 Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Biologics Targeting CCR4 Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Biologics Targeting CCR4 Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Biologics Targeting CCR4 Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Biologics Targeting CCR4 Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Biologics Targeting CCR4 Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Biologics Targeting CCR4 Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Biologics Targeting CCR4 Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Biologics Targeting CCR4 Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Biologics Targeting CCR4 Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Biologics Targeting CCR4 Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Biologics Targeting CCR4 Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Kyowa Basic Information, Biologics Targeting CCR4 Manufacturing Base, Sales Area and Its Competitors
Table 73. Kyowa Biologics Targeting CCR4 Product Portfolios and Specifications
Table 74. Kyowa Biologics Targeting CCR4 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Kyowa Main Business
Table 76. Kyowa Latest Developments
Table 77. RAPT Therapeutics, Inc Basic Information, Biologics Targeting CCR4 Manufacturing Base, Sales Area and Its Competitors
Table 78. RAPT Therapeutics, Inc Biologics Targeting CCR4 Product Portfolios and Specifications
Table 79. RAPT Therapeutics, Inc Biologics Targeting CCR4 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. RAPT Therapeutics, Inc Main Business
Table 81. RAPT Therapeutics, Inc Latest Developments
Table 82. Hanmi Pharmaceutical Co., Ltd Basic Information, Biologics Targeting CCR4 Manufacturing Base, Sales Area and Its Competitors
Table 83. Hanmi Pharmaceutical Co., Ltd Biologics Targeting CCR4 Product Portfolios and Specifications
Table 84. Hanmi Pharmaceutical Co., Ltd Biologics Targeting CCR4 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Hanmi Pharmaceutical Co., Ltd Main Business
Table 86. Hanmi Pharmaceutical Co., Ltd Latest Developments
Table 87. Eight Plus One Pharmaceutical Co Ltd Basic Information, Biologics Targeting CCR4 Manufacturing Base, Sales Area and Its Competitors
Table 88. Eight Plus One Pharmaceutical Co Ltd Biologics Targeting CCR4 Product Portfolios and Specifications
Table 89. Eight Plus One Pharmaceutical Co Ltd Biologics Targeting CCR4 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Eight Plus One Pharmaceutical Co Ltd Main Business
Table 91. Eight Plus One Pharmaceutical Co Ltd Latest Developments
Table 1. Biologics Targeting CCR4 Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Biologics Targeting CCR4 Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Monoclonal Antibodies
Table 4. Major Players of Small Molecule Chemicals
Table 5. Global Biologics Targeting CCR4 Sales by Type (2021-2026) & (K Units)
Table 6. Global Biologics Targeting CCR4 Sales Market Share by Type (2021-2026)
Table 7. Global Biologics Targeting CCR4 Revenue by Type (2021-2026) & ($ million)
Table 8. Global Biologics Targeting CCR4 Revenue Market Share by Type (2021-2026)
Table 9. Global Biologics Targeting CCR4 Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Biologics Targeting CCR4 Sale by Application (2021-2026) & (K Units)
Table 11. Global Biologics Targeting CCR4 Sale Market Share by Application (2021-2026)
Table 12. Global Biologics Targeting CCR4 Revenue by Application (2021-2026) & ($ million)
Table 13. Global Biologics Targeting CCR4 Revenue Market Share by Application (2021-2026)
Table 14. Global Biologics Targeting CCR4 Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Biologics Targeting CCR4 Sales by Company (2021-2026) & (K Units)
Table 16. Global Biologics Targeting CCR4 Sales Market Share by Company (2021-2026)
Table 17. Global Biologics Targeting CCR4 Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Biologics Targeting CCR4 Revenue Market Share by Company (2021-2026)
Table 19. Global Biologics Targeting CCR4 Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Biologics Targeting CCR4 Producing Area Distribution and Sales Area
Table 21. Players Biologics Targeting CCR4 Products Offered
Table 22. Biologics Targeting CCR4 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Biologics Targeting CCR4 Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Biologics Targeting CCR4 Sales Market Share Geographic Region (2021-2026)
Table 27. Global Biologics Targeting CCR4 Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Biologics Targeting CCR4 Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Biologics Targeting CCR4 Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Biologics Targeting CCR4 Sales Market Share by Country/Region (2021-2026)
Table 31. Global Biologics Targeting CCR4 Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Biologics Targeting CCR4 Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Biologics Targeting CCR4 Sales by Country (2021-2026) & (K Units)
Table 34. Americas Biologics Targeting CCR4 Sales Market Share by Country (2021-2026)
Table 35. Americas Biologics Targeting CCR4 Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Biologics Targeting CCR4 Sales by Type (2021-2026) & (K Units)
Table 37. Americas Biologics Targeting CCR4 Sales by Application (2021-2026) & (K Units)
Table 38. APAC Biologics Targeting CCR4 Sales by Region (2021-2026) & (K Units)
Table 39. APAC Biologics Targeting CCR4 Sales Market Share by Region (2021-2026)
Table 40. APAC Biologics Targeting CCR4 Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Biologics Targeting CCR4 Sales by Type (2021-2026) & (K Units)
Table 42. APAC Biologics Targeting CCR4 Sales by Application (2021-2026) & (K Units)
Table 43. Europe Biologics Targeting CCR4 Sales by Country (2021-2026) & (K Units)
Table 44. Europe Biologics Targeting CCR4 Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Biologics Targeting CCR4 Sales by Type (2021-2026) & (K Units)
Table 46. Europe Biologics Targeting CCR4 Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Biologics Targeting CCR4 Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Biologics Targeting CCR4 Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Biologics Targeting CCR4 Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Biologics Targeting CCR4 Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Biologics Targeting CCR4
Table 52. Key Market Challenges & Risks of Biologics Targeting CCR4
Table 53. Key Industry Trends of Biologics Targeting CCR4
Table 54. Biologics Targeting CCR4 Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Biologics Targeting CCR4 Distributors List
Table 57. Biologics Targeting CCR4 Customer List
Table 58. Global Biologics Targeting CCR4 Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Biologics Targeting CCR4 Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Biologics Targeting CCR4 Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Biologics Targeting CCR4 Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Biologics Targeting CCR4 Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Biologics Targeting CCR4 Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Biologics Targeting CCR4 Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Biologics Targeting CCR4 Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Biologics Targeting CCR4 Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Biologics Targeting CCR4 Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Biologics Targeting CCR4 Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Biologics Targeting CCR4 Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Biologics Targeting CCR4 Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Biologics Targeting CCR4 Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Kyowa Basic Information, Biologics Targeting CCR4 Manufacturing Base, Sales Area and Its Competitors
Table 73. Kyowa Biologics Targeting CCR4 Product Portfolios and Specifications
Table 74. Kyowa Biologics Targeting CCR4 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Kyowa Main Business
Table 76. Kyowa Latest Developments
Table 77. RAPT Therapeutics, Inc Basic Information, Biologics Targeting CCR4 Manufacturing Base, Sales Area and Its Competitors
Table 78. RAPT Therapeutics, Inc Biologics Targeting CCR4 Product Portfolios and Specifications
Table 79. RAPT Therapeutics, Inc Biologics Targeting CCR4 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. RAPT Therapeutics, Inc Main Business
Table 81. RAPT Therapeutics, Inc Latest Developments
Table 82. Hanmi Pharmaceutical Co., Ltd Basic Information, Biologics Targeting CCR4 Manufacturing Base, Sales Area and Its Competitors
Table 83. Hanmi Pharmaceutical Co., Ltd Biologics Targeting CCR4 Product Portfolios and Specifications
Table 84. Hanmi Pharmaceutical Co., Ltd Biologics Targeting CCR4 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Hanmi Pharmaceutical Co., Ltd Main Business
Table 86. Hanmi Pharmaceutical Co., Ltd Latest Developments
Table 87. Eight Plus One Pharmaceutical Co Ltd Basic Information, Biologics Targeting CCR4 Manufacturing Base, Sales Area and Its Competitors
Table 88. Eight Plus One Pharmaceutical Co Ltd Biologics Targeting CCR4 Product Portfolios and Specifications
Table 89. Eight Plus One Pharmaceutical Co Ltd Biologics Targeting CCR4 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Eight Plus One Pharmaceutical Co Ltd Main Business
Table 91. Eight Plus One Pharmaceutical Co Ltd Latest Developments
LIST OF FIGURES
Figure 1. Picture of Biologics Targeting CCR4
Figure 2. Biologics Targeting CCR4 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Biologics Targeting CCR4 Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Biologics Targeting CCR4 Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Biologics Targeting CCR4 Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Biologics Targeting CCR4 Sales Market Share by Country/Region (2025)
Figure 10. Biologics Targeting CCR4 Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Monoclonal Antibodies
Figure 12. Product Picture of Small Molecule Chemicals
Figure 13. Global Biologics Targeting CCR4 Sales Market Share by Type in 2026
Figure 14. Global Biologics Targeting CCR4 Revenue Market Share by Type (2021-2026)
Figure 15. Biologics Targeting CCR4 Consumed in S?zary Syndrome
Figure 16. Global Biologics Targeting CCR4 Market: S?zary Syndrome (2021-2026) & (K Units)
Figure 17. Biologics Targeting CCR4 Consumed in Mycosis Fungoides
Figure 18. Global Biologics Targeting CCR4 Market: Mycosis Fungoides (2021-2026) & (K Units)
Figure 19. Global Biologics Targeting CCR4 Sale Market Share by Application (2025)
Figure 20. Global Biologics Targeting CCR4 Revenue Market Share by Application in 2026
Figure 21. Biologics Targeting CCR4 Sales by Company in 2026 (K Units)
Figure 22. Global Biologics Targeting CCR4 Sales Market Share by Company in 2026
Figure 23. Biologics Targeting CCR4 Revenue by Company in 2026 ($ millions)
Figure 24. Global Biologics Targeting CCR4 Revenue Market Share by Company in 2026
Figure 25. Global Biologics Targeting CCR4 Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Biologics Targeting CCR4 Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Biologics Targeting CCR4 Sales 2021-2026 (K Units)
Figure 28. Americas Biologics Targeting CCR4 Revenue 2021-2026 ($ millions)
Figure 29. APAC Biologics Targeting CCR4 Sales 2021-2026 (K Units)
Figure 30. APAC Biologics Targeting CCR4 Revenue 2021-2026 ($ millions)
Figure 31. Europe Biologics Targeting CCR4 Sales 2021-2026 (K Units)
Figure 32. Europe Biologics Targeting CCR4 Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Biologics Targeting CCR4 Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa Biologics Targeting CCR4 Revenue 2021-2026 ($ millions)
Figure 35. Americas Biologics Targeting CCR4 Sales Market Share by Country in 2026
Figure 36. Americas Biologics Targeting CCR4 Revenue Market Share by Country (2021-2026)
Figure 37. Americas Biologics Targeting CCR4 Sales Market Share by Type (2021-2026)
Figure 38. Americas Biologics Targeting CCR4 Sales Market Share by Application (2021-2026)
Figure 39. United States Biologics Targeting CCR4 Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Biologics Targeting CCR4 Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Biologics Targeting CCR4 Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Biologics Targeting CCR4 Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Biologics Targeting CCR4 Sales Market Share by Region in 2026
Figure 44. APAC Biologics Targeting CCR4 Revenue Market Share by Region (2021-2026)
Figure 45. APAC Biologics Targeting CCR4 Sales Market Share by Type (2021-2026)
Figure 46. APAC Biologics Targeting CCR4 Sales Market Share by Application (2021-2026)
Figure 47. China Biologics Targeting CCR4 Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Biologics Targeting CCR4 Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Biologics Targeting CCR4 Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Biologics Targeting CCR4 Revenue Growth 2021-2026 ($ millions)
Figure 51. India Biologics Targeting CCR4 Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Biologics Targeting CCR4 Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Biologics Targeting CCR4 Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Biologics Targeting CCR4 Sales Market Share by Country in 2026
Figure 55. Europe Biologics Targeting CCR4 Revenue Market Share by Country (2021-2026)
Figure 56. Europe Biologics Targeting CCR4 Sales Market Share by Type (2021-2026)
Figure 57. Europe Biologics Targeting CCR4 Sales Market Share by Application (2021-2026)
Figure 58. Germany Biologics Targeting CCR4 Revenue Growth 2021-2026 ($ millions)
Figure 59. France Biologics Targeting CCR4 Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Biologics Targeting CCR4 Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Biologics Targeting CCR4 Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Biologics Targeting CCR4 Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Biologics Targeting CCR4 Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Biologics Targeting CCR4 Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Biologics Targeting CCR4 Sales Market Share by Application (2021-2026)
Figure 66. Egypt Biologics Targeting CCR4 Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Biologics Targeting CCR4 Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Biologics Targeting CCR4 Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Biologics Targeting CCR4 Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Biologics Targeting CCR4 Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Biologics Targeting CCR4 in 2026
Figure 72. Manufacturing Process Analysis of Biologics Targeting CCR4
Figure 73. Industry Chain Structure of Biologics Targeting CCR4
Figure 74. Channels of Distribution
Figure 75. Global Biologics Targeting CCR4 Sales Market Forecast by Region (2027-2032)
Figure 76. Global Biologics Targeting CCR4 Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Biologics Targeting CCR4 Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Biologics Targeting CCR4 Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Biologics Targeting CCR4 Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Biologics Targeting CCR4 Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Biologics Targeting CCR4
Figure 2. Biologics Targeting CCR4 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Biologics Targeting CCR4 Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Biologics Targeting CCR4 Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Biologics Targeting CCR4 Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Biologics Targeting CCR4 Sales Market Share by Country/Region (2025)
Figure 10. Biologics Targeting CCR4 Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Monoclonal Antibodies
Figure 12. Product Picture of Small Molecule Chemicals
Figure 13. Global Biologics Targeting CCR4 Sales Market Share by Type in 2026
Figure 14. Global Biologics Targeting CCR4 Revenue Market Share by Type (2021-2026)
Figure 15. Biologics Targeting CCR4 Consumed in S?zary Syndrome
Figure 16. Global Biologics Targeting CCR4 Market: S?zary Syndrome (2021-2026) & (K Units)
Figure 17. Biologics Targeting CCR4 Consumed in Mycosis Fungoides
Figure 18. Global Biologics Targeting CCR4 Market: Mycosis Fungoides (2021-2026) & (K Units)
Figure 19. Global Biologics Targeting CCR4 Sale Market Share by Application (2025)
Figure 20. Global Biologics Targeting CCR4 Revenue Market Share by Application in 2026
Figure 21. Biologics Targeting CCR4 Sales by Company in 2026 (K Units)
Figure 22. Global Biologics Targeting CCR4 Sales Market Share by Company in 2026
Figure 23. Biologics Targeting CCR4 Revenue by Company in 2026 ($ millions)
Figure 24. Global Biologics Targeting CCR4 Revenue Market Share by Company in 2026
Figure 25. Global Biologics Targeting CCR4 Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Biologics Targeting CCR4 Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Biologics Targeting CCR4 Sales 2021-2026 (K Units)
Figure 28. Americas Biologics Targeting CCR4 Revenue 2021-2026 ($ millions)
Figure 29. APAC Biologics Targeting CCR4 Sales 2021-2026 (K Units)
Figure 30. APAC Biologics Targeting CCR4 Revenue 2021-2026 ($ millions)
Figure 31. Europe Biologics Targeting CCR4 Sales 2021-2026 (K Units)
Figure 32. Europe Biologics Targeting CCR4 Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Biologics Targeting CCR4 Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa Biologics Targeting CCR4 Revenue 2021-2026 ($ millions)
Figure 35. Americas Biologics Targeting CCR4 Sales Market Share by Country in 2026
Figure 36. Americas Biologics Targeting CCR4 Revenue Market Share by Country (2021-2026)
Figure 37. Americas Biologics Targeting CCR4 Sales Market Share by Type (2021-2026)
Figure 38. Americas Biologics Targeting CCR4 Sales Market Share by Application (2021-2026)
Figure 39. United States Biologics Targeting CCR4 Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Biologics Targeting CCR4 Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Biologics Targeting CCR4 Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Biologics Targeting CCR4 Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Biologics Targeting CCR4 Sales Market Share by Region in 2026
Figure 44. APAC Biologics Targeting CCR4 Revenue Market Share by Region (2021-2026)
Figure 45. APAC Biologics Targeting CCR4 Sales Market Share by Type (2021-2026)
Figure 46. APAC Biologics Targeting CCR4 Sales Market Share by Application (2021-2026)
Figure 47. China Biologics Targeting CCR4 Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Biologics Targeting CCR4 Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Biologics Targeting CCR4 Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Biologics Targeting CCR4 Revenue Growth 2021-2026 ($ millions)
Figure 51. India Biologics Targeting CCR4 Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Biologics Targeting CCR4 Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Biologics Targeting CCR4 Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Biologics Targeting CCR4 Sales Market Share by Country in 2026
Figure 55. Europe Biologics Targeting CCR4 Revenue Market Share by Country (2021-2026)
Figure 56. Europe Biologics Targeting CCR4 Sales Market Share by Type (2021-2026)
Figure 57. Europe Biologics Targeting CCR4 Sales Market Share by Application (2021-2026)
Figure 58. Germany Biologics Targeting CCR4 Revenue Growth 2021-2026 ($ millions)
Figure 59. France Biologics Targeting CCR4 Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Biologics Targeting CCR4 Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Biologics Targeting CCR4 Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Biologics Targeting CCR4 Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Biologics Targeting CCR4 Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Biologics Targeting CCR4 Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Biologics Targeting CCR4 Sales Market Share by Application (2021-2026)
Figure 66. Egypt Biologics Targeting CCR4 Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Biologics Targeting CCR4 Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Biologics Targeting CCR4 Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Biologics Targeting CCR4 Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Biologics Targeting CCR4 Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Biologics Targeting CCR4 in 2026
Figure 72. Manufacturing Process Analysis of Biologics Targeting CCR4
Figure 73. Industry Chain Structure of Biologics Targeting CCR4
Figure 74. Channels of Distribution
Figure 75. Global Biologics Targeting CCR4 Sales Market Forecast by Region (2027-2032)
Figure 76. Global Biologics Targeting CCR4 Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Biologics Targeting CCR4 Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Biologics Targeting CCR4 Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Biologics Targeting CCR4 Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Biologics Targeting CCR4 Revenue Market Share Forecast by Application (2027-2032)
